SWI QuickPicks Ratings Report

Our Analyst coverage on VG Life Sciences (VGLS) was well received last week, the stock increased by 35% the next day and is holding steady on increased volume. This is not a day-trading stock, but the company deserves your attention, much more to come.

We have added three newcomers to our QuickPicks list: 

Achaogen, Inc. (AKAO), 
FS Investment Corporation (FSIC) 
TriVascular Technologies, Inc. (TRIV) 

Achaogen is a clinical-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant ("MDR") gram-negative infections. We are happy to add AKAO to our roster of biotech companies that we already cover. TriVascular Technologies, Inc., a medical device company that develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms. FS Investment CorporationFS Investment Corporation is a business development company specializing in investments in debt securities.
 

We have changed five (5) stocks to neutral, downgraded two (2)
and upgraded six (6). The total portfolio value is up 2.3%.

 

We will start coverage of two new stocks for two very promising companies in a new and rapidly growing industry within the next few days. We will also add those new stocks to our SWW WatchIndex page and release two major research reports. 

Note: We deliberately do not use the terms "buy", "hold" or "sell", but instead use "neutral", "upgrade" and "downgrade" in our QuickPicks list. This is based on our philosophy that by publishing our QuickPicks list we do not promote the buying and selling of specific stocks, but want to assist with your overall investment decision and provide some guidance.  We have added a "Trend" column, which should make it easier for you to follow the ups and downs of our picks.

StockWatchIndex (SWI) is not a registered investment adviser and makes no warranty, expressed or implied, as to the accuracy, or completeness, or fitness for a purpose (investment or otherwise) of the information provided in the publications of its Newsletter, Stock Watch List or on its web sites. The provided information is not to be construed as personal financial advice, or a solicitation to buy or sell stock. Some information has been generated by what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. We have contracted with some of the companies we present on SWI as public relations consultants to keep the market and especially our subscribers informed about the companies. We may have been compensated in cash and/or stock and stock options, which may be considered a potential conflict of interest. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in its newsletter or on its web sites. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. StockWatchIndex expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. The included information is subject to change without notice.